Skip to Main Content

Paper Details

Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
Int J Epidemiol
55
2016
Cancer, HGSC, histological subtypes, low, low-grade/borderline serous cancers, non-, ovarian cancer, ovarian cancers, serous cancers, single nucleotide polymorphisms
Author NameAffiliation
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Celeste Leigh PearceUniversity of Michigan School of Public Health, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Celeste Leigh PearceUniversity of Michigan School of Public Health, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center
Wei ZhengVanderbilt University School of Medicine
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine, USA University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen Nuremberg
Diether LambrechtsVesalius Research Center, University of Leuven
Mary Anne RossingFred Hutchinson Cancer Research Center, University of Washington
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Jennifer A DohertyThe Geisel School of Medicine at Dartmouth
Jenny Chang-ClaudeGerman Cancer Research Center
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, USA Community and Population Health Research Institute
Lynne R WilkensUniversity of Hawaii Cancer Center
Lynne R WilkensUniversity of Hawaii Cancer Center
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Ellen L GoodeMayo Clinic
Brooke L FridleyUniversity of Kansas Medical Center
Stacey J WinhamMayo Clinic
Graham G GilesThe University of Melbourne, Monash University
Roger L MilneThe University of Melbourne
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineMemorial Sloan Kettering Cancer Center
Joellen M SchildkrautDuke University Medical Center, Duke Cancer Institute
Andrew BerchuckDuke University Medical Center
Elisa V BanderaRutgers Cancer Institute of New Jersey
Lambertus A KiemeneyRadboud University Medical Center, Radboud Institute for Health Sciences
Tanja PejovicOregon Health & Science University, USA Knight Cancer Institute
Angela Brooks-WilsonSimon Fraser University
Linda E KelemenMedical University of South Carolina
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jan LubinskiInternational Hereditary Cancer Center, Pomeranian Medical University
Jacek GronwaldInternational Hereditary Cancer Center, Pomeranian Medical University
Jacek GronwaldInternational Hereditary Cancer Center, Pomeranian Medical University
Janusz MenkiszakPomeranian Medical University
Nicolas WentzensenNational Cancer Institute
Louise A BrintonNational Cancer Institute
Louise A BrintonNational Cancer Institute
Jolanta LissowskaThe Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Jolanta LissowskaThe Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Honglin SongUniversity of Cambridge
Jonathan TyrerUniversity of Cambridge
Ian G CampbellPeter MacCallum Cancer Centre, University of Melbourne
Rosalind GlasspoolThe Beatson West of Scotland Cancer Centre
Alice S WhittemoreStanford University School of Medicine
Weiva SiehStanford University School of Medicine
Joseph H RothsteinStanford University School of Medicine
John R McLaughlin
  • 1 - 50

Datasets